CO5251413A1 - NEW USE - Google Patents

NEW USE

Info

Publication number
CO5251413A1
CO5251413A1 CO00092011A CO00092011A CO5251413A1 CO 5251413 A1 CO5251413 A1 CO 5251413A1 CO 00092011 A CO00092011 A CO 00092011A CO 00092011 A CO00092011 A CO 00092011A CO 5251413 A1 CO5251413 A1 CO 5251413A1
Authority
CO
Colombia
Prior art keywords
new use
occlusive article
skin
occlusive
buffering
Prior art date
Application number
CO00092011A
Other languages
Spanish (es)
Inventor
Bo Runeman
Jan Faergemann
Larko Olle
Original Assignee
Sca Hygiene Prod Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sca Hygiene Prod Ab filed Critical Sca Hygiene Prod Ab
Publication of CO5251413A1 publication Critical patent/CO5251413A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El uso de un ingrediente farmacéuticamente aceptable no tóxico y no irritante capaz de amortiguar dentro del rango de pH de 2,0 a 5,5 para preparar un artículo oclusivo de la piel o un artículo oclusivo de la membrana mucosa para impedir irritaciones de la piel y lesiones causadas por Candida albicans.The use of a non-toxic and non-irritating pharmaceutically acceptable ingredient capable of buffering within the pH range of 2.0 to 5.5 to prepare an occlusive article of the skin or an occlusive article of the mucous membrane to prevent skin irritations and injuries caused by Candida albicans.

CO00092011A 1999-12-02 2000-12-01 NEW USE CO5251413A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904387A SE521431C2 (en) 1999-12-02 1999-12-02 Use of a pH buffering substance to prevent skin infections caused by Candida Albicans

Publications (1)

Publication Number Publication Date
CO5251413A1 true CO5251413A1 (en) 2003-02-28

Family

ID=20417954

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00092011A CO5251413A1 (en) 1999-12-02 2000-12-01 NEW USE

Country Status (13)

Country Link
EP (1) EP1233746A1 (en)
JP (1) JP2003515544A (en)
KR (1) KR20020060249A (en)
AU (1) AU778633B2 (en)
BR (1) BR0016005A (en)
CA (1) CA2392102A1 (en)
CO (1) CO5251413A1 (en)
MX (1) MXPA02005211A (en)
PL (1) PL355410A1 (en)
RU (1) RU2002117294A (en)
SE (1) SE521431C2 (en)
SK (1) SK7882002A3 (en)
WO (1) WO2001039582A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274154B1 (en) 1999-04-07 2001-08-14 Belle L Chou Aloe Vera glove and manufacturing method
US6630152B2 (en) 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20030204893A1 (en) * 2002-05-02 2003-11-06 Chou Belle L. Elastomeric flexible article and manufacturing method
US9757285B2 (en) 2011-03-07 2017-09-12 Edgewell Personal Care Brands, Llc Absorbent article including a buffer composition
DE102011106046A1 (en) 2011-06-30 2013-01-03 Paul Hartmann Ag Wound Care Product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794034A (en) * 1973-02-27 1974-02-26 J Jones Odor reductant body waste pad
PH23760A (en) * 1985-05-15 1989-11-03 Procter & Gamble Disposable absorbent articles
US4842593A (en) * 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
WO1995019190A1 (en) * 1994-01-17 1995-07-20 Carlo Alfredo Graziani Napkin with buffer substance
SE511838C2 (en) * 1997-06-17 1999-12-06 Sca Hygiene Prod Ab Reduction of undesirable side effects when using absorbent articles by means of pH control
PT1024814E (en) * 1997-10-22 2007-11-29 Mayo Foundation Use of antifungal agents for the topical treatment of fungus-induced mucositis
ATE289206T1 (en) * 1998-03-12 2005-03-15 Procter & Gamble PROTON DONATORS IN SUCTION BODY

Also Published As

Publication number Publication date
SE521431C2 (en) 2003-11-04
WO2001039582A1 (en) 2001-06-07
SE9904387L (en) 2001-06-03
SE9904387D0 (en) 1999-12-02
CA2392102A1 (en) 2001-06-07
PL355410A1 (en) 2004-04-19
SK7882002A3 (en) 2002-12-03
AU778633B2 (en) 2004-12-16
BR0016005A (en) 2002-07-30
KR20020060249A (en) 2002-07-16
EP1233746A1 (en) 2002-08-28
MXPA02005211A (en) 2002-12-09
RU2002117294A (en) 2004-01-27
AU1906301A (en) 2001-06-12
JP2003515544A (en) 2003-05-07

Similar Documents

Publication Publication Date Title
DK1792610T3 (en) Therapeutic bioadhesive system with long-term release
IL186655A0 (en) Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
MXPA03005464A (en) Antiviral agents.
SV2003001107A (en) IMIDAZOTRIAZINAS REF.LEA 35368
HN2001000190A (en) SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS
RS41904A (en) Macrolides
BR0112962A (en) Pharmaceutical compositions for the treatment of painful inflammatory and ulcerative conditions of most epithelial surfaces such as mucositis, stomatitis and behcet syndrome
ES2267706T3 (en) AGENTS AS NICOTINAMIDE OR CARDR FOR THE TREATMENT OF SKIN DISORDERS.
SE0102036D0 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
TWI264312B (en) Highly flexible transdermal therapeutic system with nicotine as active ingredient
CO5251413A1 (en) NEW USE
BR0116060A (en) Dronedarone pharmaceutical composition for parenteral administration
DK1957037T3 (en) Pharmaceutical preparation for nasal use of fentanyl
SE0001916D0 (en) Novel formulation
BR0210632A (en) Parasitic disease treatment
BR9910305A (en) Vaccine
SV2003001061A (en) NEW HETEROCICLOS 3 REF.LEA 35361-SV
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
ES2170649B1 (en) USE OF CDP-HILL IN THE TREATMENT OF ALCOHOLIC ABSTINENCE.
AR029829A1 (en) USE OF A CASEINE DERIVATIVE FOR THE PREPARATION OF COSMETIC, PHARMACEUTICAL AND VETERINARY COMPOSITIONS AND THE PREPARED COMPOSITIONS ASUS, USEFUL TO INHIBIT THE ADHESION OF THE PATHOGRAPHIC FLORA TO THE SKIN
SV2002000639A (en) PHENOXYPHENYL ALCANOSULFONATES REF. READ 34813-SV
DE50111782D1 (en) Propellant-free spray formulations
PT1212049E (en) USE OF TIANFENICOL FOR THE TREATMENT OF INFECTIONS BY CHLAMYDIA PNEUMONIAE
AR014432A1 (en) BIOADHESIVE COMPOSITION AND METHODS FOR THE TOPICAL ADMINISTRATION OF ACTIVE AGENTS
HUP0004475A2 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FC Application refused